5u4r
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='5u4r' size='340' side='right' caption='[[5u4r]], [[Resolution|resolution]] 1.76Å' scene=''> | <StructureSection load='5u4r' size='340' side='right' caption='[[5u4r]], [[Resolution|resolution]] 1.76Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5u4r]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5U4R OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5U4R FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5u4r]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5U4R OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5U4R FirstGlance]. <br> |
</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5u4r FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5u4r OCA], [http://pdbe.org/5u4r PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5u4r RCSB], [http://www.ebi.ac.uk/pdbsum/5u4r PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5u4r ProSAT]</span></td></tr> | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5u4r FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5u4r OCA], [http://pdbe.org/5u4r PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5u4r RCSB], [http://www.ebi.ac.uk/pdbsum/5u4r PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5u4r ProSAT]</span></td></tr> | ||
</table> | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Antigenic drift and shift of influenza strains underscore the need for broadly protective influenza vaccines. One strategy is to design immunogens that elicit B cell responses against conserved epitopes on the hemagglutinin (HA) stem. To better understand the elicitation of HA stem-targeted B cells to group 1 and group 2 influenza subtypes, we compared the memory B cell response to group 2 H7N9 and group 1 H5N1 vaccines in humans. Upon H7N9 vaccination, almost half of the HA stem-specific response recognized the group 1 and group 2 subtypes, whereas the response to H5N1 was largely group 1-specific. Immunoglobulin repertoire analysis of HA-specific B cells indicated that the H7N9 and H5N1 vaccines induced genetically similar cross-group HA stem-binding B cells, albeit at a much higher frequency upon H7N9 vaccination. These data suggest that a group 2-based stem immunogen could prove more effective than a group 1 immunogen at eliciting broad cross-group protection in humans. | ||
+ | |||
+ | Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans.,Andrews SF, Joyce MG, Chambers MJ, Gillespie RA, Kanekiyo M, Leung K, Yang ES, Tsybovsky Y, Wheatley AK, Crank MC, Boyington JC, Prabhakaran MS, Narpala SR, Chen X, Bailer RT, Chen G, Coates E, Kwong PD, Koup RA, Mascola JR, Graham BS, Ledgerwood JE, McDermott AB Sci Immunol. 2017 Jul 14;2(13). pii: eaan2676. doi: 10.1126/sciimmunol.aan2676. PMID:28783708<ref>PMID:28783708</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 5u4r" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
+ | [[Category: Human]] | ||
[[Category: Andrews, S F]] | [[Category: Andrews, S F]] | ||
[[Category: Joyce, M G]] | [[Category: Joyce, M G]] |
Revision as of 20:46, 2 December 2018
Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 53-1A09 Fab.
|